REPORT ID 20761

Global Personalized Medicine Market

Publish Date
16-Nov
Pages
0
Format
Electronic (PDF)

According to Stratistics MRC, the Global Personalized Medicine Market accounted for $94.49 billion in 2015 and is expected to reach $178.78 million by 2022 growing at a CAGR of 9.5% from 2015 to 2022.  Increased healthcare spending, growing incidence of cancer and rising adoption of next generation sequencing are few factors expected to fuel the market growth. Furthermore, government reimbursements for personalized medicine and regulatory scenario are the factors anticipated to propel the demand during the forecast period. However, complexity involved in usage of the drugs, huge development costs and inter-patient changeability of effects are some of the factors hindering the market.

North America commanded the market owing to technological advancements and increased R&D investments by various biotechnology companies in the region. However, the Asia-Pacific is expected to observe significant growth over the forecast period owing to the presence of a huge base of unmet market demand. Personalized medicines have major impact on SME’s and offer lucrative opportunities for these companies to expand their industrial boundaries across the world.

Some of the key players in the market are Siemens Healthcare Diagnostics Inc., Sanofi, Quest Diagnostics, Qiagen Inc., Pfizer Inc., Laboratory Corporation of America, Illumina Inc., GE Healthcare, Foundation Medicine Inc., CardioDx Inc., Bristol-Myers Squibb, Becton Dickinson & Co., Asuragen Inc., Amgen Inc., Agendia NV, Abbott and 3G Biotech.

End Users Covered:
• Academic Institutes and Research Laboratories
• Bio and health informatics companies
• Contract Research Organizations
• Hospitals
• Molecular Diagnostic Laboratories and Testing facilities
• Other End Users
o Venture capitalists
o Service providers
o Partners

Applications Covered:
• Health Informatics
• Companion Diagnostics
• Clinical Research
• Biomarker identification

Therapeutic areas Covered:
• Infectious Diseases
o Hospital Acquired Infections
o HIV
o HCV
o HBV
• Coagulation Therapy
• Autoimmune Diseases
• Cardiovascular Diseases
• CNS Disorders
• Diabetes
• Blood Transfusion Safety
• Cancer Management
o Blood Markers
o Circulating Tumor Cells
o Tissue-based Tests
• Others

Products Covered:
• Personalized Medicine Therapeutics 
o Genomic Medicine
o Medical Devices
o Pharmaceutical
• Personalized Nutrition & Wellness 
o Alternative Medicine
o Complementary Medicine
o Retail Nutrition
• Personalized Medical Care 
o Diseases Management
o Healthcare Information Technology
o Telemedicine
• Personalized Medicine Diagnostics 
o Direct-to-consumer Diagnostics
o Esoteric Lab Services
o Esoteric Lab Tests
o Genetic Testing

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain     
o Rest of Europe 
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific      
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements 
			   
1 Executive Summary            
              
2 Preface             
 2.1 Abstract            
 2.2 Stake Holders           
 2.3 Research Scope           
 2.4 Research Methodology          
  2.4.1 Data Mining          
  2.4.2 Data Analysis          
  2.4.3 Data Validation          
  2.4.4 Research Approach          
 2.5 Research Sources           
  2.5.1 Primary Research Sources         
  2.5.2 Secondary Research Sources         
  2.5.3 Assumptions          
              
3 Market Trend Analysis           
 3.1 Introduction           
 3.2 Drivers            
 3.3 Restraints           
 3.4 Opportunities           
 3.5 Threats            
 3.6 Application Analysis          
 3.7 End User Analysis           
 3.8 Product Analysis           
 3.9 Emerging Markets           
              
4 Porters Five Force Analysis           
 4.1 Bargaining power of suppliers          
 4.2 Bargaining power of buyers          
 4.3 Threat of substitutes          
 4.4 Threat of new entrants          
 4.5 Competitive rivalry           
              
5 Global Personalized Medicine Market, By End User         
 5.1 Introduction           
 5.2 Academic Institutes and Research Laboratories        
 5.3 Bio and health informatics companies         
 5.4 Contract Research Organizations         
 5.5 Hospitals            
 5.6 Molecular Diagnostic Laboratories and Testing facilities       
 5.7 Other End Users           
  5.7.1 Venture capitalists          
  5.7.2 Service providers          
  5.7.3 Partners           
              
6 Global Personalized Medicine Market, By Application        
 6.1 Introduction           
 6.2 Health Informatics           
 6.3 Companion Diagnostics          
 6.4 Clinical Research           
 6.5 Biomarker identification          
              
7 Global Personalized Medicine Market, By Therapeutic area        
 7.1 Introduction           
 7.2 Infectious Diseases           
  7.2.1 Hospital Acquired Infections         
  7.2.2 HIV           
  7.2.3 HCV           
  7.2.4 HBV           
 7.3 Coagulation Therapy          
 7.4 Autoimmune Diseases          
 7.5 Cardiovascular Diseases          
 7.6 CNS Disorders           
 7.7 Diabetes            
 7.8 Blood Transfusion Safety          
 7.9 Cancer Management          
  7.9.1 Blood Markers          
  7.9.2 Circulating Tumor Cells         
  7.9.3 Tissue-based Tests          
 7.10 Others            
              
8 Global Personalized Medicine Market, By Product         
 8.1 Introduction           
 8.2 Personalized Medicine Therapeutics         
  8.2.1 Genomic Medicine          
  8.2.2 Medical Devices          
  8.2.3 Pharmaceutical          
 8.3 Personalized Nutrition & Wellness         
  8.3.1 Alternative Medicine         
  8.3.2 Complementary Medicine         
  8.3.3 Retail Nutrition          
 8.4 Personalized Medical Care          
  8.4.1 Diseases Management         
  8.4.2 Healthcare Information Technology        
  8.4.3 Telemedicine          
 8.5 Personalized Medicine Diagnostics         
  8.5.1 Direct-to-consumer Diagnostics        
  8.5.2 Esoteric Lab Services         
  8.5.3 Esoteric Lab Tests          
  8.5.4 Genetic Testing          
              
9 Global Personalized Medicine Market, By Geography        
 9.1 North America           
  9.1.1 US           
  9.1.2 Canada           
  9.1.3 Mexico           
 9.2 Europe            
  9.2.1 Germany           
  9.2.2 France           
  9.2.3 Italy           
  9.2.4 UK           
  9.2.5 Spain           
  9.2.6 Rest of Europe          
 9.3 Asia Pacific           
  9.3.1 Japan           
  9.3.2 China           
  9.3.3 India           
  9.3.4 Australia           
  9.3.5 New Zealand          
  9.3.6 Rest of Asia Pacific          
 9.4 Rest of the World           
  9.4.1 Middle East          
  9.4.2 Brazil           
  9.4.3 Argentina          
  9.4.4 South Africa          
  9.4.5 Egypt           
              
10 Key Developments            
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures       
 10.2 Acquisitions & Mergers          
 10.3 New Product Launch          
 10.4 Expansions           
 10.5 Other Key Strategies          
              
11 Company Profiling            
 11.1 Siemens Healthcare Diagnostics Inc.         
 11.2 Sanofi            
 11.3 Quest Diagnostics           
 11.4 Qiagen Inc.           
 11.5 Pfizer Inc.           
 11.6 Laboratory Corporation of America         
 11.7 Illumina Inc.           
 11.11 GE Healthcare           
 11.9 Foundation Medicine Inc.          
 11.10 CardioDx Inc.           
 11.11 Bristol-Myers Squibb          
 11.12 Becton Dickinson & Co.          
 11.13 Asuragen Inc           
 11.14 Amgen Inc.           
 11.15 Agendia NV           
 11.16 Abbott            
 11.17 3G Biotech    

List of Tables             
1 Global Personalized Medicine Market Outlook, By Region (2013-2022) ($MN)      
2 Global Personalized Medicine Market Outlook, By Academic Institutes and Research Laboratories (2013-2022) ($MN)  
3 Global Personalized Medicine Market Outlook, By Bio and health informatics companies (2013-2022) ($MN)   
4 Global Personalized Medicine Market Outlook, By Contract Research Organizations (2013-2022) ($MN)    
5 Global Personalized Medicine Market Outlook, By Hospitals (2013-2022) ($MN)      
6 Global Personalized Medicine Market Outlook, By Molecular Diagnostic Laboratories and Testing facilities (2013-2022) ($MN) 
7 Global Personalized Medicine Market Outlook, By Other End Users (2013-2022) ($MN)     
8 Global Personalized Medicine Market Outlook, By Venture capitalists (2013-2022) ($MN)     
9 Global Personalized Medicine Market Outlook, By Service providers (2013-2022) ($MN)     
10 Global Personalized Medicine Market Outlook, By Partners (2013-2022) ($MN)      
11 Global Personalized Medicine Market Outlook, By Application (2013-2022) ($MN)      
12 Global Personalized Medicine Market Outlook, By Health Informatics (2013-2022) ($MN)     
13 Global Personalized Medicine Market Outlook, By Companion Diagnostics (2013-2022) ($MN)     
14 Global Personalized Medicine Market Outlook, By Clinical Research (2013-2022) ($MN)     
15 Global Personalized Medicine Market Outlook, By Biomarker identification (2013-2022) ($MN)    
16 Global Personalized Medicine Market Outlook, By Therapeutic area (2013-2022) ($MN)     
17 Global Personalized Medicine Market Outlook, By Infectious Diseases (2013-2022) ($MN)     
18 Global Personalized Medicine Market Outlook, By Hospital Acquired Infections (2013-2022) ($MN)    
19 Global Personalized Medicine Market Outlook, By HIV (2013-2022) ($MN)      
20 Global Personalized Medicine Market Outlook, By HCV (2013-2022) ($MN)      
21 Global Personalized Medicine Market Outlook, By HBV (2013-2022) ($MN)      
22 Global Personalized Medicine Market Outlook, By Coagulation Therapy (2013-2022) ($MN)     
23 Global Personalized Medicine Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)     
24 Global Personalized Medicine Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)    
25 Global Personalized Medicine Market Outlook, By CNS Disorders (2013-2022) ($MN)     
26 Global Personalized Medicine Market Outlook, By Diabetes (2013-2022) ($MN)      
27 Global Personalized Medicine Market Outlook, By Blood Transfusion Safety (2013-2022) ($MN)    
28 Global Personalized Medicine Market Outlook, By Cancer Management (2013-2022) ($MN)     
29 Global Personalized Medicine Market Outlook, By Blood Markers (2013-2022) ($MN)     
30 Global Personalized Medicine Market Outlook, By Circulating Tumor Cells (2013-2022) ($MN)     
31 Global Personalized Medicine Market Outlook, By Tissue-based Tests (2013-2022) ($MN)     
32 Global Personalized Medicine Market Outlook, By Others (2013-2022) ($MN)      
33 Global Personalized Medicine Market Outlook, By Product (2013-2022) ($MN)      
34 Global Personalized Medicine Market Outlook, By Personalized Medicine Therapeutics (2013-2022) ($MN)   
35 Global Personalized Medicine Market Outlook, By Genomic Medicine (2013-2022) ($MN)     
36 Global Personalized Medicine Market Outlook, By Medical Devices (2013-2022) ($MN)     
37 Global Personalized Medicine Market Outlook, By Pharmaceutical (2013-2022) ($MN)     
38 Global Personalized Medicine Market Outlook, By Personalized Nutrition & Wellness (2013-2022) ($MN)   
39 Global Personalized Medicine Market Outlook, By Alternative Medicine (2013-2022) ($MN)     
40 Global Personalized Medicine Market Outlook, By Complementary Medicine (2013-2022) ($MN)    
41 Global Personalized Medicine Market Outlook, By Retail Nutrition (2013-2022) ($MN)     
42 Global Personalized Medicine Market Outlook, By Personalized Medical Care (2013-2022) ($MN)    
43 Global Personalized Medicine Market Outlook, By Diseases Management (2013-2022) ($MN)     
44 Global Personalized Medicine Market Outlook, By Healthcare Information Technology (2013-2022) ($MN)   
45 Global Personalized Medicine Market Outlook, By Telemedicine (2013-2022) ($MN)     
46 Global Personalized Medicine Market Outlook, By Personalized Medicine Diagnostics (2013-2022) ($MN)   
47 Global Personalized Medicine Market Outlook, By Direct-to-consumer Diagnostics (2013-2022) ($MN)    
48 Global Personalized Medicine Market Outlook, By Esoteric Lab Services (2013-2022) ($MN)     
49 Global Personalized Medicine Market Outlook, By Esoteric Lab Tests (2013-2022) ($MN)     
50 Global Personalized Medicine Market Outlook, By Genetic Testing (2013-2022) ($MN)     
51 North America Personalized Medicine Market Outlook, By Country (2013-2022) ($MN)     
52 North America Personalized Medicine Market Outlook, By Academic Institutes and Research Laboratories (2013-2022) ($MN)  
53 North America Personalized Medicine Market Outlook, By Bio and health informatics companies (2013-2022) ($MN)  
54 North America Personalized Medicine Market Outlook, By Contract Research Organizations (2013-2022) ($MN)   
55 North America Personalized Medicine Market Outlook, By Hospitals (2013-2022) ($MN)     
56 North America Personalized Medicine Market Outlook, By Molecular Diagnostic Laboratories and Testing facilities (2013-2022) ($MN) 
57 North America Personalized Medicine Market Outlook, By Other End Users (2013-2022) ($MN)    
58 North America Personalized Medicine Market Outlook, By Venture capitalists (2013-2022) ($MN)    
59 North America Personalized Medicine Market Outlook, By Service providers (2013-2022) ($MN)    
60 North America Personalized Medicine Market Outlook, By Partners (2013-2022) ($MN)     
61 North America Personalized Medicine Market Outlook, By Application (2013-2022) ($MN)     
62 North America Personalized Medicine Market Outlook, By Health Informatics (2013-2022) ($MN)    
63 North America Personalized Medicine Market Outlook, By Companion Diagnostics (2013-2022) ($MN)    
64 North America Personalized Medicine Market Outlook, By Clinical Research (2013-2022) ($MN)    
65 North America Personalized Medicine Market Outlook, By Biomarker identification (2013-2022) ($MN)    
66 North America Personalized Medicine Market Outlook, By Therapeutic area (2013-2022) ($MN)    
67 North America Personalized Medicine Market Outlook, By Infectious Diseases (2013-2022) ($MN)    
68 North America Personalized Medicine Market Outlook, By Hospital Acquired Infections (2013-2022) ($MN)   
69 North America Personalized Medicine Market Outlook, By HIV (2013-2022) ($MN)      
70 North America Personalized Medicine Market Outlook, By HCV (2013-2022) ($MN)      
71 North America Personalized Medicine Market Outlook, By HBV (2013-2022) ($MN)      
72 North America Personalized Medicine Market Outlook, By Coagulation Therapy (2013-2022) ($MN)    
73 North America Personalized Medicine Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)    
74 North America Personalized Medicine Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)    
75 North America Personalized Medicine Market Outlook, By CNS Disorders (2013-2022) ($MN)     
76 North America Personalized Medicine Market Outlook, By Diabetes (2013-2022) ($MN)     
77 North America Personalized Medicine Market Outlook, By Blood Transfusion Safety (2013-2022) ($MN)    
78 North America Personalized Medicine Market Outlook, By Cancer Management (2013-2022) ($MN)    
79 North America Personalized Medicine Market Outlook, By Blood Markers (2013-2022) ($MN)     
80 North America Personalized Medicine Market Outlook, By Circulating Tumor Cells (2013-2022) ($MN)    
81 North America Personalized Medicine Market Outlook, By Tissue-based Tests (2013-2022) ($MN)    
82 North America Personalized Medicine Market Outlook, By Others (2013-2022) ($MN)     
83 North America Personalized Medicine Market Outlook, By Product (2013-2022) ($MN)     
84 North America Personalized Medicine Market Outlook, By Personalized Medicine Therapeutics (2013-2022) ($MN)   
85 North America Personalized Medicine Market Outlook, By Genomic Medicine (2013-2022) ($MN)    
86 North America Personalized Medicine Market Outlook, By Medical Devices (2013-2022) ($MN)    
87 North America Personalized Medicine Market Outlook, By Pharmaceutical (2013-2022) ($MN)     
88 North America Personalized Medicine Market Outlook, By Personalized Nutrition & Wellness (2013-2022) ($MN)   
89 North America Personalized Medicine Market Outlook, By Alternative Medicine (2013-2022) ($MN)    
90 North America Personalized Medicine Market Outlook, By Complementary Medicine (2013-2022) ($MN)   
91 North America Personalized Medicine Market Outlook, By Retail Nutrition (2013-2022) ($MN)     
92 North America Personalized Medicine Market Outlook, By Personalized Medical Care (2013-2022) ($MN)   
93 North America Personalized Medicine Market Outlook, By Diseases Management (2013-2022) ($MN)    
94 North America Personalized Medicine Market Outlook, By Healthcare Information Technology (2013-2022) ($MN)   
95 North America Personalized Medicine Market Outlook, By Telemedicine (2013-2022) ($MN)     
96 North America Personalized Medicine Market Outlook, By Personalized Medicine Diagnostics (2013-2022) ($MN)   
97 North America Personalized Medicine Market Outlook, By Direct-to-consumer Diagnostics (2013-2022) ($MN)   
98 North America Personalized Medicine Market Outlook, By Esoteric Lab Services (2013-2022) ($MN)    
99 North America Personalized Medicine Market Outlook, By Esoteric Lab Tests (2013-2022) ($MN)    
100 North America Personalized Medicine Market Outlook, By Genetic Testing (2013-2022) ($MN)     
101 Europe Personalized Medicine Market Outlook, By Country (2013-2022) ($MN)      
102 Europe Personalized Medicine Market Outlook, By Academic Institutes and Research Laboratories (